ANRS HB 05 MULTICENTER STUDY EVALUATING EFFICACY AND SAFETY OF CLEVUDINE MONOTHERAPY VERSUS TENOFOVIR MONOTHERAPY VERSUS COMBINATION THERAPY OF CLEVUDINE AND TENOFOVIR FOR 96 WEEKS IN HBEAG NEGATIVE PATIENTS WITH CHRONIC HEPATITIS B, NAÏVE TO ANTI-VHB THERAPY: